Curtiss-Wright Corporation 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed on December 12, 2024, by Curtiss-Wright Corporation (NYSE: CW). The report details the adoption of a written trading plan under Rule 10b5-1 to facilitate share repurchases. The plan is scheduled to commence on December 16, 2024.
Key Financial Metrics
This filing does not report operational financial results such as revenue, profit, cash flow, or margins. The only financial metric disclosed relates to capital allocation:
- Total Share Repurchase Authorization: $240 million available under current authorizations.
- Trading Plan Amount: $100 million allocated for this specific Rule 10b5-1 plan.
- Remaining Authorization Post-Plan: Expected to be $140 million upon completion.
Material Changes
The material event reported is the formal establishment of a $100 million share repurchase trading plan. This action reduces the remaining authorized capital for future repurchases from $240 million to an expected $140 million once the plan is fully executed.
Guidance, Outlook, and Risks
Outlook and Execution: The trading plan is expected to be fully utilized by December 31, 2024. Purchases will be made up to the maximum daily target volume allowable under Rule 10b-18. The plan allows repurchases during periods when the company might otherwise be restricted by trading blackout periods or insider trading laws.
Risks and Contingencies: The filing includes standard forward-looking statement disclaimers. Risks include stock price and volume volatility, adverse developments in exchange-traded securities, and unplanned capital investment requirements. The company does not undertake to update forward-looking statements.
Investor Verification Checklist
- Verify the execution of the $100 million repurchase plan in subsequent Form 10-Q or 10-K filings.
- Confirm the remaining share repurchase authorization balance after the plan concludes on or before December 31, 2024.
- Review the press release dated December 16, 2024 (Exhibit 99.1) for additional details on the transaction.
- Monitor for any subsequent Rule 10b5-1 plans if the company intends to utilize the remaining $140 million authorization.